GENEVA, Aug. 7 -- ALVEUS THERAPEUTICS INC. filed a patent application (EP2026/052504) for “GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR (GIPR) ANTAGONISTS”. With publication no. WO/2026/162754, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07C 275/34
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....